Stockscreener 앱 받기
119.36
1.49%
-1.83
시간 외 거래:
119.53
0.17
+0.14%
Gilead Sciences Inc 주식(GILD)의 최신 뉴스
Lombard Odier Asset Management Switzerland SA Raises Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer - Business Wire
Jump Financial LLC Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Three Catalysts Driving Investor Attention Toward Gilead Sciences - AD HOC NEWS
Gilead Sciences, Inc. $GILD Shares Sold by Bank of Nova Scotia - MarketBeat
ASH25: CAR-T Leaders Gilead, J&J Show in Multiple Myeloma; Fulcrum Rises on Sickle Cell Data - BioSpace
WINTON GROUP Ltd Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
ASH: Gilead preps filing for anito-cel on iMMagine-1 data - pharmaphorum
What Does the Market Think About Gilead Sciences Inc? - Benzinga
Gilead Sciences, Inc. $GILD Shares Bought by Natixis - MarketBeat
35,296 Shares in Gilead Sciences, Inc. $GILD Bought by SVB Wealth LLC - MarketBeat
Gilead moves ahead on Chess Hatch project - San Mateo Daily Journal
L2 Asset Management LLC Buys 28,592 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
GILD's Yescarta Shows Promising Results for Lymphoma Patients - GuruFocus
GILD's Kite Unveils Promising CAR T-Cell Therapy Results at ASH Meeting - GuruFocus
ASH: Gilead’s Kite Plots 2026 Launch For Anito-Cel For Multiple Myeloma - Citeline News & Insights
ASH: Anito-cel strengthens best-in-class potential as Gilead's Kite preps for launch - Fierce Biotech
New data from Gilead, Arcellx multiple myeloma CAR-T suggest benefit over rival treatment - statnews.com
Federated Hermes Inc. Sells 1,885,664 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Position Decreased by Brown Advisory Inc. - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Baird Financial Group Inc. - MarketBeat
Why The Narrative Around Gilead Sciences Is Shifting After HIV And Oncology Updates - Yahoo Finance
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition - GlobeNewswire Inc.
First Trust Advisors LP Sells 1,512,069 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Arrowstreet Capital Limited Partnership Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat
1832 Asset Management L.P. Makes New $4.69 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Marshall Wace LLP Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat
Dodge & Cox Lowers Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Epoch Investment Partners Inc. Has $95.16 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by CW Advisors LLC - MarketBeat
Amundi Purchases 1,614,355 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Sprint Bioscience (Q3 review)Gilead deal a strong confirmation - marketscreener.com
Redeye: Sprint Bioscience (Q3 review)Gilead deal a strong confirmation - TradingView
Is Gilead Sciences Inc. (GIS) stock good for long term investingJuly 2025 Rallies & Stock Timing and Entry Methods - Newser
Gilead's Seat at the Table of Conversations Centered Around HIV - Gilead Sciences
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - Yahoo Finance
VestGen Advisors LLC Lowers Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Channing Capital Management LLC Purchases 43,875 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by Guggenheim Capital LLC - MarketBeat
Groupe la Francaise Has $3.92 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Stock Outlook: Mizuho Lifts Target Amid Stronger Biktarvy Timeline - MSN
Gilead (GILD) Valuation After Fresh Buy Rating and Extended Biktarvy Exclusivity Boost Investor Confidence - Yahoo Finance UK
Gilead Sciences, Inc. $GILD Shares Bought by Loomis Sayles & Co. L P - MarketBeat
Invesco Ltd. Buys 3,394,330 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Jeffrey Bluestone Sells 5,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Health Hires: Goodwin Partner Joins Incyte, Gilead GC Exits - Law360
Gilead Sciences (NASDAQ:GILD) CEO Sells $1,265,400.00 in Stock - MarketBeat
Gilead Sciences (NASDAQ:GILD) Director Sells $356,515.50 in Stock - MarketBeat
Gilead Sciences (NASDAQ:GILD) Director Sells $356,670.66 in Stock - MarketBeat
Transcript : Gilead Sciences, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11 - marketscreener.com
Insider Activity Update: Jeffrey Bluestone Executes Options Exercise, Resulting In $296K At Gilead Sciences - Benzinga
2,222 Shares in Gilead Sciences, Inc. $GILD Purchased by Valued Retirements Inc. - MarketBeat
Panagora Asset Management Inc. Has $175.96 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Shelton Capital Management Sells 3,380 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Prossimo Advisors LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Will Gilead Sciences Inc. (Common Stock) (GIS0) stock outperform value peersWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus
Gilead Sciences director Kramer sells $713,186 in stock By Investing.com - Investing.com India
Dir Kramer Sells 5,611 ($713.2K) Of Gilead Sciences Inc [GILD] - TradingView
Chmn O'Day Sells 10,000 ($1.3M) Of Gilead Sciences Inc [GILD] - TradingView
News Is Out hosting Gilead’s Choose U World AIDS Day panel - Dallas Voice
Orleans Capital Management Corp LA Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Railway Pension Investments Ltd Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Grantham Mayo Van Otterloo & Co. LLC Increases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gifford Fong Associates Sells 25,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (GILD) Investigation: Bronstein, Gewirtz - The National Law Review
Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver - Finviz
West Family Investments Inc. Has $1.35 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
New York State Common Retirement Fund Sells 15,100 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Schroder Investment Management Group Trims Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Scotia Capital Inc. Sells 17,090 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Level Four Advisory Services LLC Trims Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Laurel Wealth Advisors LLC Acquires 6,593 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Edgewood Management LLC Sells 2,394 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
1.71%
자본화:
|
볼륨(24시간):